The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1
- 1 May 1977
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 13 (5) , 819-830
- https://doi.org/10.1016/0090-6980(77)90212-x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Renal function in cirrhosis and the effects of prostaglandin A1The American Journal of Medicine, 1974
- Recovery from “Hepatorenal Syndrome” after Orthotopic Liver TransplantationNew England Journal of Medicine, 1973
- Effects of prostaglandins E 1 , A 1 , and F 2 on renal handling of salt and waterAmerican Journal of Physiology-Legacy Content, 1973
- Treatment of hepatic coma and hepatorenal syndrome: Mechanism of action of L-dopa and aramineThe American Journal of Surgery, 1972
- Renal failure in the patient with cirrhosis: The role of active vasoconstrictionThe American Journal of Medicine, 1970
- Functional Renal Failure in CirrhosisAnnals of Internal Medicine, 1970
- Transplantation of Cadaveric Kidneys from Patients with Hepatorenal SyndromeNew England Journal of Medicine, 1969
- Systemic Vasoconstrictor and Renal Vasodilator Effects of PLV-2 (Octapressin) in ManCirculation, 1968
- Spontaneous Recovery from the Hepatorenal SyndromeNew England Journal of Medicine, 1965
- Clinical Report on Hydro-Peritoneum, based on an analysis of forty-six casesThe Lancet Healthy Longevity, 1863